Delivery Order SPE2DB24D1104-SPE2DB25FYEM5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) under a firm fixed-price contract. The delivery order, valued at $2,593.20 with an ultimate completion date of August 15, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability...
- The Defense Logistics Agency awarded a delivery order valued at $1,248.90 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL). This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for completion by July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. NovoLog is a rapid-acting insulin product...
- The Defense Logistics Agency awarded a $2,045.20 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of NovoLog 100 Unit/mL vials (10mL) to be delivered by July 29, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating open competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,737.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of NovoLog 100 Unit/mL vials (10mL). The contract, which is a child order under a larger indefinite delivery contract, carries an ultimate completion date of August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a non-competitive, competitively awarded transaction...
- The Defense Logistics Agency awarded a delivery order valued at $1,397.84 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 unit/mL vials (10 mL) under a firm fixed-price contract. This non-set-aside competitive award was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,171.80 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10mL) with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a $3,033.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of NovoLog 100 Unit/mL vials (10mL). This non-set-aside contract was competitively awarded and is scheduled for completion by August 4, 2025, with performance to take place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting the federal government's medical...
- The Defense Logistics Agency awarded a delivery order valued at $4,819.02 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL). The contract, classified as a firm fixed price delivery order with an ultimate completion date of August 18, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,383.81 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed price delivery order was awarded without set-aside designation through open competition and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,664.69 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of NovoLog 100 Unit/mL vials (10mL). The award is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYEM5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,265.12 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL). This firm fixed price contract, with performance in Conshohocken, Pennsylvania, represents a child delivery order issued under a larger indefinite delivery contract vehicle. The award involves no set-aside designation, indicating it was competitively awarded through open procurement processes. This delivery order falls under AmerisourceBergen Drug Corp's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, providing medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/12/25 |